Universe Pharmaceuticals Inc
1 hedge funds and large institutions have $3.6K invested in Universe Pharmaceuticals Inc in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
0.19% less ownership
Funds ownership: 0.36% → 0.17% (-0.19%)
50% less funds holding
Funds holding: 2 → 1 (-1)
60% less capital invested
Capital invested by funds: $9.04K → $3.6K (-$5.44K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$9.04K |
UPC Hedge Fund Activity: Q4 2025 in Review
1 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q4 2025, worth a combined $3.6K — down 60% from $9.04K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of UPC and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $4.21K. The largest seller was Osaic Holdings, exiting entirely with an estimated $9.04K sold.
- 1 institutional investor held Universe Pharmaceuticals Inc (UPC) as of Q4 2025, down from 2 in Q3 2025.
- Funds reported $3.6K of Universe Pharmaceuticals Inc stock for Q4 2025, down 60% quarter-over-quarter.
- 0 funds opened new Universe Pharmaceuticals Inc positions in Q4 2025 and 1 closed out, a net change of -1 holder.
- The largest Universe Pharmaceuticals Inc buyer in Q4 2025 was UBS Group, an estimated $4.21K added.
- The largest Universe Pharmaceuticals Inc seller in Q4 2025 was Osaic Holdings, an estimated $9.04K sold.
Based on aggregated 13F filings for Q4 2025.